Symbicort

NHS Direct launches new Patient Support Programme

NHS Direct is working with AstraZeneca to provide a telephone review and follow-up programme for all patients who have been prescribed Symbicort Maintenance and Reliever Therapy (SMART) by their doctor. ... NHS Direct is working with Anglo-Swedish

FDA concerned over GSK asthma drug risk

With annual sales expected to be in the region of USD 1bn, Flutiform, if approved, would compete with Advair/Seretide and AstraZeneca's Symbicort (budesonide/ formoterol).

SkyePharma looks at options after bid approach

The drug could generate annual sales of more than $1bn (? 575m) and would rival GSK's Seretide and AstraZeneca's Symbicort if approved.

People, November, 2005

He currently directs the global programme for Symbicort and the UK programme for Zyprexa.

A healthy week

AZ, however, fought back. The company said that patients taking Symbicort had been under-dosed as they were given an average of just 1.8 puffs of the treatment every day. ... An earlier study where patients received an average of 3.4 puffs of Symbicort a

[ Previous 5 results ] 5 6 7 8 9 10 11 12 13 14 [ Next 5 results ]